Issue 2/2014
Content (10 Articles)
Market access of cancer drugs in European countries: improving resource allocation
Kim Pauwels, Isabelle Huys, Minne Casteels, Katelijne De Nys, Steven Simoens
The success story of trastuzumab emtansine, a targeted therapy in HER2-positive breast cancer
Véronique Diéras, Thomas Bachelot
Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine
Daniela Laura Papademetrio, Victoria Cavaliere, Tania Simunovich, Susana Costantino, María Dolores Campos, Tomás Lombardo, Claudio Marcelo Fader Kaiser, Élida Álvarez
Anti-leukemic response of a NSAID, tolfenamic acid
Robert M. Sutphin, Sarah F. Connelly, Chris M. Lee, Umesh T. Sankpal, Don Eslin, Moeez Khan, Hima Pius, Riyaz Basha
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases
Johnny Kao, Chien-Ting Chen, Charles C. L. Tong, Stuart H. Packer, Myron Schwartz, Shu-hsia Chen, Max W. Sung
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
M. Di Bartolomeo, F. Pietrantonio, F. Perrone, K. F. Dotti, A. Lampis, C. Bertan, E. Beretta, L. Rimassa, C. Carbone, P. Biondani, R. Passalacqua, S. Pilotti, E. Bajetta
A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells
Nanjing Lin, Wenyun Zheng, Linfeng Li, Hui Liu, Tianwen Wang, Ping Wang, Xingyuan Ma
Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?
Nazım Emrah Koçer, Fazilet Kayaselçuk
A case of fatal cetuximab-induced interstitial lung disease during the first weeks of treatment
Alaaeldin Shablak, Andrew Conn
Erratum to: Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer
Luís León, Roberto García-Figueiras, Cristina Suárez, Antonia Arjonilla, Javier Puente, Blanca Vargas, Maria José Méndez Vidal, Carmen Sebastiá